Cargando…

MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1

Osteosarcoma is the most common primary bone tumour. Increasing evidence has demonstrated the pathogenic role of microRNA (miRNAs) dysregulation in tumour development. miR‐379 was previously reported to function as an oncogenic or tumour‐suppressing miRNA in a tissue‐dependent manner. However, its f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zheng, Shen, Jianxiong, Chan, Matthew T. V., Wu, William Ka Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264134/
https://www.ncbi.nlm.nih.gov/pubmed/27781416
http://dx.doi.org/10.1111/jcmm.12966
_version_ 1782500042448306176
author Li, Zheng
Shen, Jianxiong
Chan, Matthew T. V.
Wu, William Ka Kei
author_facet Li, Zheng
Shen, Jianxiong
Chan, Matthew T. V.
Wu, William Ka Kei
author_sort Li, Zheng
collection PubMed
description Osteosarcoma is the most common primary bone tumour. Increasing evidence has demonstrated the pathogenic role of microRNA (miRNAs) dysregulation in tumour development. miR‐379 was previously reported to function as an oncogenic or tumour‐suppressing miRNA in a tissue‐dependent manner. However, its function in osteosarcoma remains unknown. In this study, we found that the expression of miR‐379 was downregulated in osteosarcoma tissues and cell lines. Further functional characterization revealed that miR‐379 suppressed osteosarcoma cell proliferation and invasion in vitro and retarded the growth of osteosarcoma xenografts in vivo. Mechanistically, PDK1 was identified as the direct target of miR‐379 in osteosarcoma, in which PDK1 expression was up‐regulated and showed inverse correlation with miR‐379. Enforced expression of PDK1 promoted osteosarcoma cell proliferation and rescued the anti‐proliferative effect of miR‐379. These data suggest that miR‐379 could function as a tumour‐suppressing miRNA via targeting PDK1 in osteosarcoma.
format Online
Article
Text
id pubmed-5264134
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52641342017-02-01 MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1 Li, Zheng Shen, Jianxiong Chan, Matthew T. V. Wu, William Ka Kei J Cell Mol Med Original Articles Osteosarcoma is the most common primary bone tumour. Increasing evidence has demonstrated the pathogenic role of microRNA (miRNAs) dysregulation in tumour development. miR‐379 was previously reported to function as an oncogenic or tumour‐suppressing miRNA in a tissue‐dependent manner. However, its function in osteosarcoma remains unknown. In this study, we found that the expression of miR‐379 was downregulated in osteosarcoma tissues and cell lines. Further functional characterization revealed that miR‐379 suppressed osteosarcoma cell proliferation and invasion in vitro and retarded the growth of osteosarcoma xenografts in vivo. Mechanistically, PDK1 was identified as the direct target of miR‐379 in osteosarcoma, in which PDK1 expression was up‐regulated and showed inverse correlation with miR‐379. Enforced expression of PDK1 promoted osteosarcoma cell proliferation and rescued the anti‐proliferative effect of miR‐379. These data suggest that miR‐379 could function as a tumour‐suppressing miRNA via targeting PDK1 in osteosarcoma. John Wiley and Sons Inc. 2016-10-25 2017-02 /pmc/articles/PMC5264134/ /pubmed/27781416 http://dx.doi.org/10.1111/jcmm.12966 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Li, Zheng
Shen, Jianxiong
Chan, Matthew T. V.
Wu, William Ka Kei
MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
title MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
title_full MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
title_fullStr MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
title_full_unstemmed MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
title_short MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
title_sort microrna‐379 suppresses osteosarcoma progression by targeting pdk1
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264134/
https://www.ncbi.nlm.nih.gov/pubmed/27781416
http://dx.doi.org/10.1111/jcmm.12966
work_keys_str_mv AT lizheng microrna379suppressesosteosarcomaprogressionbytargetingpdk1
AT shenjianxiong microrna379suppressesosteosarcomaprogressionbytargetingpdk1
AT chanmatthewtv microrna379suppressesosteosarcomaprogressionbytargetingpdk1
AT wuwilliamkakei microrna379suppressesosteosarcomaprogressionbytargetingpdk1